University of Minnesota to test three drugs for COVID-19 Patients

University of Minnesota to test three drugs for COVID-19 patients

Author
VP Jakub Tolar
March 13, 2020

Colleagues,

In our ongoing effort to work on possible prevention and treatments for COVID-19, I am pleased to share that we are getting ready to launch three new clinical trials to determine if drugs originally used for high blood pressure, Ebola and malaria can help people exposed to COVID-19. We expect to enroll the first patient as early as today.

One trial focuses on people who have been exposed to the virus but who do not have any symptoms. The second trial focuses on people who have tested positive for the virus but have mild symptoms and don’t require hospitalization. The third trial, which was recently approved by the NIH, is for hospitalized patients. You can read more details on these trials in today’s Star Tribune.

We are prepared to deliver care for people we serve with knowledge and willingness to take a stand and lead the national response to COVID-19 infection. The University of Minnesota has been designated by federal officials as the regional isolation and containment center for Minnesota, Wisconsin, Michigan and Illinois.

Lead with calm and confidence, and let us know how we can do better,

Jakub Tolar, MD, PhD
Campus Public Health Officer
Vice President for Clinical Affairs

Other News

Interior of MIDB facility
The ability to connect with people from other areas takes our own work to a higher level and makes an impact on our communities.
UMN health sciences learners at Itasca Biological Station
Participation in the Itasca Ecohealth IPE Experience serves as part of the 1Health interprofessional education curriculum.
IPE inters 2023
The theme of this year’s program is to work in cooperation with those who receive and provide care.